Bridging the Gap: The Crucial Role of Private Healthcare in Achieving Universal Health Coverage

By Staff Writer

September 1, 2023

The World Bank Group (2017) estimates that at least half of the world’s population lacks access to basic healthcare. Moreover, nearly 100 million people are plunged into poverty annually due to healthcare expenses. These gaps in health provision are notably severe in low-income countries (LICs), where the majority of those facing impoverishing health expenses reside.

Universal Health Coverage (UHC) – defined as the global aim to ensure everyone receives the health services they need without suffering financial hardship – has been proposed as a solution to this pressing issue. The World Health Organisation (WHO) conceptualizes UHC as a ‘cube’ comprising three key dimensions: population coverage, service coverage, and financial risk protection.


Source: Authors’ own elaboration, adapted from Kutsin (2013) and the WHO UHC cube (World Health Organisation, 2010; Kutzin, 2013).

However, the role of private healthcare in achieving UHC remains a subject of ongoing debate. While the public and private health sectors interact and shape each other’s performance, the unclear boundaries between the two make it difficult to define a UHC role for the private sector.

Private-for-profit (PFP) providers, motivated by commercial interests, and private not-for-profits (PNFPs), usually driven by philanthropic motives, are the two main types of private healthcare providers. The central role of profit in PFPs has ignited debate on their ability to adequately serve the poor and whether they can be contracted by governments to advance UHC goals.

The informal sector in LICs, which includes traditional birth attendants and healers, unlicensed drug shops, and market stalls, provides a substantial proportion of healthcare, particularly for the poor. However, the quality of care in both the public and private sectors in LICs often falls short, particularly at the lower end of the market.

A recent study extends the debate on the role of private healthcare in LICs by systematically reviewing recently published literature. They found that while formal private providers typically operate in already well-served urban settings, informal and not-for-profit ones cater to patients in underserved rural areas and generally at the lower end of the health market.

However, improving the quality and financing of informal providers may be key to expanding UHC in LICs. Given their ubiquitous nature and diversity of contributions, mechanisms for (self) accreditation will need to be strengthened to guarantee a minimum level of service quality from these actors.

Quality and effectiveness should be considered core principles of universal coverage and represent an additional dimension of the UHC cube in its own right.

Reference url

Recent Posts

datopotamab deruxtecan approval
   

FDA Grants Datopotamab Deruxtecan Approval for HR-Positive Breast Cancer Treatment

💡 *What does the FDA’s latest approval mean for patients with advanced breast cancer?*
Datopotamab deruxtecan (Datroway) has just been approved for treating unresectable or metastatic HR-positive, HER2-negative breast cancer, offering new hope for patients who have already undergone multiple therapies. This breakthrough, stemming from the TROPION-Breast01 trial, showcases significant improvements in progression-free survival rates—a vital advancement in cancer care.

Curious about the implications of this treatment for both healthcare providers and patients? Dive into the full article to learn more!

#SyenzaNews #oncology #HealthcareInnovation

surrogate endpoints guidance
          

Surrogate Endpoints Guidance: New International Report Enhances HTA Practices

🔍 Are surrogate endpoints the key to shaping the future of health technology assessment?

A new report led by NICE reveals standardized guidance for using surrogate endpoints in health economic models, providing clarity and validation tools for HTA decisions. This collaborative effort across multiple global agencies aims to enhance predictions of long-term health benefits from short-term data.

Jump into the article to explore these impactful insights and learn how this guidance is set to improve health technology evaluations!

#SyenzaNews #HealthEconomics #HealthcareInnovation

cervical cancer prevention
    

Cervical Cancer Prevention Strategies: Insights from South African

🌍 Did you know South African women living with HIV face a significantly higher risk of cervical cancer?

Our latest article looks into the perspectives of women and their partners regarding innovative cervical cancer prevention strategies, including the acceptability of the intravaginal 5-fluorouracil (5FU) treatment. It highlights the critical role of education and counseling in improving screening uptake and treatment adherence.

Explore how we can enhance cervical health for vulnerable populations!

#SyenzaNews #globalhealth #oncology #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.